"The science of improving lives"
Sino-implant (II)
According to United Nations estimates, about 200 million women worldwide have an unmet need for safe and effective contraception--that is, they neither want to get pregnant nor do they use a modern form of family planning. As a result, each year 70 to 80 million women face unwanted pregnancies.
Contraceptive implants, which were introduced more than 25 years ago, are one of the most effective family planning methods developed to date. Even though they have potential to reduce the number of unwanted pregnancies significantly, they are underutilized, primarily because of their high cost. Few programs and clinics are able to offer the method and stockouts are frequent.
To address these problems, FHI is facilitating the introduction of Sino-implant (II)--a long-acting, safe, and affordable contraceptive implant. Sino-implant (II) cost about 60 percent less than implants on the market in 2009, according to the Reproductive Health Supplies Coalition database. As a result, it can be offered to women on a much broader scale than the other implants and reduce the high unmet need for contraception.
Sino-implant (II) is a subdermal contraceptive implant manufactured in China by Shanghai Dahua Pharmaceutical Co., Ltd. It has an annual pregnancy rate below 1 percent. The product is composed of two thin, flexible, silicone rods, each containing 75 mg levonorgestrel (a synthetic form of the hormone progesterone). These are inserted under the skin of a woman's arm or thigh by a trained health care provider. Sino-implant (II) is currently labeled for four years of use.
According to United Nations estimates, about 200 million women worldwide have an unmet need for safe and effective contraception--that is, they neither want to get pregnant nor do they use a modern form of family planning. As a result, each year 70 to 80 million women face unwanted pregnancies.
Contraceptive implants, which were introduced more than 25 years ago, are one of the most effective family planning methods developed to date. Even though they have potential to reduce the number of unwanted pregnancies significantly, they are underutilized, primarily because of their high cost. Few programs and clinics are able to offer the method and stockouts are frequent.
To address these problems, FHI is facilitating the introduction of Sino-implant (II)--a long-acting, safe, and affordable contraceptive implant. Sino-implant (II) cost about 60 percent less than implants on the market in 2009, according to the Reproductive Health Supplies Coalition database. As a result, it can be offered to women on a much broader scale than the other implants and reduce the high unmet need for contraception.
Sino-implant (II) is a subdermal contraceptive implant manufactured in China by Shanghai Dahua Pharmaceutical Co., Ltd. It has an annual pregnancy rate below 1 percent. The product is composed of two thin, flexible, silicone rods, each containing 75 mg levonorgestrel (a synthetic form of the hormone progesterone). These are inserted under the skin of a woman's arm or thigh by a trained health care provider. Sino-implant (II) is currently labeled for four years of use.
RSS Feed